-
The 28-year-old man's tumor reached 6 pounds, and doctors successfully removed it after he was "out of food" and lost weight.
Time of Update: 2020-08-17
Recently, Professor Zhong Lin of hepatobiliary surgery at the Southern Precinct Clinic of Shanghai First People's Hospital, with the "secondary liver removal" program, first removed the tumor "starved thin" and then removed, for a huge rare liver fibroline tumor patients implemented a maximum precision excision.
-
When a famous medical consultation is carried out, the outbreak period management of blood tumors.
Time of Update: 2020-08-17
"People's famous doctor" special planning to launch the "war epidemic - famous medical consultation" series, the authority of the department of the famous medical group online live broadcast answer questions, for the vast number of netizens free voluntary consultation!
sweep the two-dimensional code above into the Health Times WeChat Live Room, watch the live broadcast and ask questions online.
-
Locating difficult tumor diagnosis and treatment! Fudan Oncology Pudong Hospital District trial run.
Time of Update: 2020-08-17
Guo Xiaomao introduced that in the newly opened oncology hospital Pudong Hospital District, will also carry out a comprehensive outpatient single-disease multidisciplinary diagnosis and treatment, the implementation of high-quality full coverage of the new model of cancer clinical research.
-
The outbreak period management of lymphoma when the famous medical consultation is carried out.
Time of Update: 2020-08-17
March 2 (Monday) 15:00-16:00, "People's Famous Medical" new crown pneumonia prevention and treatment special planning series live broadcast "when the famous medical consultation", invited to The Beijing University Cancer Hospital Party Secretary, director of the Department of Internal Medicine, Professor Zhu Jun, director of lymphoma detailed answers, online consultation.
-
Several new cancer drugs have made progress, keystone pharmaceutical stocks bucked the trend, up more than 9%
Time of Update: 2020-08-17
CS3002 is a selective inhibitor of cell cycle protein-dependent kinase 4 and 6 ("CDK4/6") developed by Keystone Pharmaceuticals.
On August 25, , Keystone Pharmaceuticals announced that avapritinib's I/II phase bridge registration trial, developed by Cornerstone Pharmaceuticals Partner Blueprint Medicines Corporation, would enable the first subject-administered drug in China.
-
Roche's innovative cancer immunology drug has been approved for first-line treatment of a wide range of small cell lung cancers.
Time of Update: 2020-08-17
Recently, China's State Drug Administration officially approved Roche's innovative cancer immunology drug Tai Sanqi ® combined chemotherapy for the first-line treatment of a wide range of small cell lung cancer.
-
How can artificial intelligence help primary digestive tract tumor screening? Listen to experts on the medical future!
Time of Update: 2020-08-17
This forum, will combine artificial intelligence, 5G technology, magnetic capsule gastroscope and other technologies, explore how to achieve high-quality medical resources sinking, improve the level of grass-roots diagnosis and treatment, to help China's digestive tract cancer screening.
-
That's great! Chinese experts have discovered new anti-cancer molecules that provide a means for precise cancer treatment.
Time of Update: 2020-08-17
(Health Times network end of the reporter Wei Wei Shanghai Renji Hospital Ye Jiaqi, Yuan Wei) . Recently, the study conducted by Liu Peifeng team of Liu Peifeng team and Qiu Huibin team of Shanghai Ji
-
The country's first large-scale chest tumor precision medical research center was established.
Time of Update: 2020-08-17
In order to further strengthen the development process of precision diagnosis and treatment of chest tumors in China and promote the transformation of cutting-edge research and clinical research in the field of chest tumors, on September 6th, the Shanghai Chest - and Rui Gene Precision Medical Research Center was established at Shanghai Chest Hospital.
-
Dean's Dialogue - Innovative services of the "First Medical" brand oncology hospital.
Time of Update: 2020-08-17
From November to December 2019, the Beijing Municipal Hospital Management Center, People's Daily Health Times, Beijing People's Radio City Radio (FM107.3, AM1026) jointly launched the Special Planning Series of People's Famous Medical Program "President-Dialogue" - Beijing Municipal Hospital Dean's Series, inviting 22 Beijing Hospital Directors to interview, and interact with online users around the theme of "Technological Innovation and Service Improvement".
-
Under the outbreak, colorectal tumor treatment question and answer.
Time of Update: 2020-08-17
sweep the two-dimensional code above into the Health Times WeChat Live Room, watch the live broadcast and ask questions online.
-
Price reduction of more than 60%, Lilly classic tumor chemotherapy drug Libitai belt volume procurement bid.
Time of Update: 2020-08-17
On September 25th, Lilly Pharmaceuticals developed the classic anti-tumor chemotherapy drug Libita (injection of permeitus dsodium) in the Alliance region drug centralized procurement bid.
-
From precise appointments to pathological intelligence testing, Fudan tumors play AI combination punches.
Time of Update: 2020-08-17
At present, Fudan University affiliated oncology hospital has introduced a number of artificial intelligence products, for patients to seek medical treatment to bring great convenience.
accurate appointment, AI according to the condition to help tumor patients to register 2018, Fudan University affiliated cancer hospital outpatient volume reached 1.4472 million.
-
To build a "precision prevention and control" model, Tianjin Cancer Hospital set up a liver cancer prevention and control research center.
Time of Update: 2020-08-17
Recently, the "Liver Cancer Prevention and Control Research Center" and the National Health and Health Administration Hospital Management Institute ,"a standardized training project demonstration project for primary liver cancer diagnosis and treatment" was established at Tianjin Medical University Cancer Hospital.
-
Boston Scientific acquires BTG to strengthen tumor intervention and vascular disease treatment technology.
Time of Update: 2020-08-17
Recently, Boston Scientific, a U.S. medical device company, announced that it had completed its acquisition of BTG in accordance with its previously announced restructuring plan.
-
When the famous medical consultation is carried out, the Chinese medicine treatment of malignant tumor answers questions.
Time of Update: 2020-08-17
, March 1st, 15:00-16:00, "People's Famous Medicine" live broadcast of the new crown pneumonia prevention and control special planning series live "when the famous medical consultation", invited to Beijing University of Traditional Chinese Medicine Dongzhimen Hospital, the director of blood oncology physician, professor, doctoral tutor, the World Federation of Chinese Medicine Association oncology professional committee, Beijing Chinese Medicine Research Association, the director of the Oncology Collaboration Committee Li Zhong, online.
-
When the famous medical consultation is carried out, the question and answer of the digestive tumor treatment.
Time of Update: 2020-08-17
"People's famous doctor" special planning to launch the "war epidemic - famous medical consultation" series, the authority of the department of the famous medical group online live broadcast answer questions, for the vast number of netizens free voluntary consultation!
-
The greatest concern of the death of the academician HuYamei is still the children of hematologic disease and malignant tumor.
Time of Update: 2020-08-17
(Health Times reporter Xu Wei, intern reporter Wang Aibing) " Hu Lao is a kind man, a teacher who is leading by example, a doctor who is approachable, a doctor of great love. "When it comes to the aca
-
Approval speed up! Tumor electric field therapy was qualified as an innovative medical device.
Time of Update: 2020-08-17
Recently, Reding Pharmaceuticals and Novocure announced that The State Drug Administration of China has awarded Optune, a cancer field treatment product, ® innovative medical device qualification, and the time to market in China is expected to be shortened.
-
What new possibilities can artificial intelligence bring to cancer treatment? Listen to what the experts have to say.
Time of Update: 2020-08-16
"Artificial intelligence can provide doctors with more information in clinical diagnosis and treatment, more accurate judgment of the symptoms, efficacy, reduce the cycle of drug research and development, is the premise and basis for malignant tumors to achieve personalized precision treatment", recently, the Chinese Association of Cancer Association Cancer Artificial Intelligence Professional Committee was formally established, Tianjin Cancer Hospital Vice President Professor Xu Bo was elected as the first chairman of the Committee.
